B. Herger

发表

Understanding HTLV-I protease.

S. B. Shuker, Victoria L Mariani, B. Herger, 2003, Chemistry & biology.

Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.

P. Atadja, K. Bhalla, Yonghua Yang, 2008, Blood.

Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells

A. Chinnaiyan, P. Atadja, K. Bhalla, 2006, Molecular Cancer Therapeutics.

Kinetic analysis of mutants of HTLV-I protease.

B. Herger, 2004 .

Many thanks to everyone who has seen me through this endeavor: to my mother and father, for moral and financial support, and the rest of my family, including my brother Jim, sister Jonilee, and stepfather

M. Kulis, R. Hernandez, N. Hud, 2004 .

Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells

K. Bhalla, F. Lee, V. Richon, 2006, Clinical Cancer Research.

Cotreatment withVorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate^Sensitive or Imatinib Mesylate^Resistant Chronic Myelogenous Leukemia Cells

K. Bhalla, F. Lee, V. Richon, 2006 .

Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90

P. Atadja, Yuan Ren, Jie Wu, 2007, Clinical Cancer Research.

Anti-leukemia activity of histone deacetylase (HDAC) inhibitor LBH589 involves depletion of EZH2 and DNA methyltransferase (DNMT) 1 through disruption of their chaperone association with heat shock protein (hsp) 90

P. Atadja, K. Bhalla, C. Ustun, 2007 .